DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 44701 - 44725 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name UniProt ID ▲
C1527366 Salaam Seizures ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0006826 Malignant Neoplasms ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0007847 Malignant tumor of cervix ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0013421 Dystonia ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0013384 Dyskinetic syndrome ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0014544 Epilepsy ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0234533 Generalized seizures ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0011860 Diabetes Mellitus, Non-Insulin-Dependent ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0011849 Diabetes Mellitus ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011847 Diabetes ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C1306459 Primary malignant neoplasm ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0020456 Hyperglycemia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0002395 Alzheimer's Disease ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011265 Presenile dementia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011860 Diabetes Mellitus, Non-Insulin-Dependent ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0031117 Peripheral Neuropathy ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0524620 Metabolic Syndrome X ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0020459 Hyperinsulinism ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C2239176 Liver carcinoma ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0233794 Memory impairment ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0086651 Mucopolysaccharidosis, MPS-IV-A ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0086132 Depressive Symptoms ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011854 Diabetes Mellitus, Insulin-Dependent ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0497327 Dementia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0027651 Neoplasms ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024